Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CV Sciences (CVSI) EBT Margin (2016 - 2025)

Historic EBT Margin for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to 11.73%.

  • CV Sciences' EBT Margin rose 700.0% to 11.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.34%, marking a year-over-year increase of 58100.0%. This contributed to the annual value of 15.29% for FY2024, which is 347500.0% down from last year.
  • Latest data reveals that CV Sciences reported EBT Margin of 11.73% as of Q3 2025, which was up 700.0% from 7.21% recorded in Q2 2025.
  • CV Sciences' EBT Margin's 5-year high stood at 137.56% during Q1 2023, with a 5-year trough of 180.22% in Q4 2021.
  • Its 5-year average for EBT Margin is 26.96%, with a median of 19.05% in 2024.
  • In the last 5 years, CV Sciences' EBT Margin skyrocketed by 1716300bps in 2023 and then crashed by -1531000bps in 2024.
  • Over the past 5 years, CV Sciences' EBT Margin (Quarter) stood at 180.22% in 2021, then surged by 66bps to 61.05% in 2022, then soared by 63bps to 22.63% in 2023, then increased by 16bps to 19.05% in 2024, then surged by 38bps to 11.73% in 2025.
  • Its last three reported values are 11.73% in Q3 2025, 7.21% for Q2 2025, and 2.83% during Q1 2025.